0001593968-24-000192.txt : 20240131
0001593968-24-000192.hdr.sgml : 20240131
20240131174237
ACCESSION NUMBER: 0001593968-24-000192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240125
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chang David D
CENTRAL INDEX KEY: 0001611024
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 24584158
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
primary_01.xml
PRIMARY DOCUMENT
X0508
4
2024-01-25
0001737287
Allogene Therapeutics, Inc.
ALLO
0001611024
Chang David D
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
President and CEO
false
Common Stock
2024-01-25
4
A
false
317800
0
A
4513203
D
Common Stock
1201108
I
See footnote
Common Stock
856044
I
See footnote
Common Stock
856044
I
See footnote
Stock Option (Right to buy)
3.2
2024-01-25
4
A
false
1123535
0
A
2034-01-25
Common Stock
1123535
1123535
D
Includes 1492 shares of the Issuer's common stock acquired by the reporting person on September 15,2023 pursuant to an employee stock purchase program.
Securities held in the name of the Chang 2006 Family Trust
Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.
/s/Earl Douglas, Attorney-in-Fact
2024-01-31